Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL

Approved

STANDARD

TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL

Bioprojet Pharma🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 6, 2024
Approval ID: 417db179124e8e1a
Company: Bioprojet Pharma
Type: Standard

Approval Details

Approval Id: 417db179124e8e1a
Drug Cima Aemps Name: TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL
Register Number: 88685
Holder Company Name: Bioprojet Pharma
Marketing Company Name: Bioprojet Pharma
Holder Company Detail Path: /organization/bioprojet-pharma
Marketing Company Detail Path: /organization/bioprojet-pharma
Authorization Date: 2024-02-06
Dosage Form: SUSPENSIÓN ORAL
Dose: 4 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Bioprojet Pharma
Company Detail Path: /organization/bioprojet-pharma

Company Information

Pharmaceutical Company Name: Bioprojet Pharma
Country Name: Belgium
City Name: unknown,unknown,country_be
Address: Unknown Belgian address

Active Ingredients

RACECADOTRILO

4 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 6, 2024

Approval ID

417db179124e8e1a

Type

Standard

Back to CIMA-AEMPS Approvals